Doximity, Inc.
DOCS Healthcare Health Information Services
Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025.
- Revenue
- +3.57%
- EPS
- −42.4%
- Free cash flow
- +1.87%
Quarter to September 2026, against a year earlier
Follow DOCS
Alert me
Doximity, Inc. (DOCS) Book value per share
Doximity, Inc.'s book value per share at the end of fiscal 2026 was 5.1×, down 12.3% from 5.8× in fiscal 2025. At the end of the quarter to 30 September 2026 it was 5.2×. Over the past ten years it has ranged from 0.0× (fiscal 2019) to 5.8× (fiscal 2025); the current reading is higher than 75% of that period. Doximity, Inc. ranks 19th of 44 Health Information Services companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2026 | 5.1× | (12.25%) |
| FY2025 | 5.8× | 22.25% |
| FY2024 | 4.7× | (5.22%) |
| FY2023 | 5.0× | (6.94%) |
| FY2022 | 5.4× | 169.59% |
| FY2021 | 2.0× | 61.13% |
| FY2020 | 1.2× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 5.2× | 3.56% |
| Jun 2026 | 5.0× | (1.31%) |
| Mar 2026 | 5.1× | (2.66%) |
| Dec 2025 | 5.2× | (10.50%) |
| 24 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| HQY HealthEquity, Inc. compare | 23.9× |
| WAY Waystar Holding Corp. compare | 21.0× |
| BTSG BrightSpring Health Services, Inc. compare | 10.5× |
| PRVA Privia Health Group, Inc. compare | 6.8× |
| DOCS Doximity, Inc. | 5.2× |
| HNGE Hinge Health Inc. compare | 4.4× |
| SDGR Schrodinger, Inc. compare | 4.0× |
| HTFL Heartflow, Inc. compare | 3.2× |
| TEM Tempus AI, Inc. compare | 2.8× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on DOCS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement